Cite
HARVARD Citation
Saba, N. et al. (2014). Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck. Cancer. 120 (24), pp. 3940-3951. [Online].